OPYL LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.019 AUD | -5.00% |
|
-13.64% | -32.14% |
| Mar. 22 | Opyl Receives Offer for Patient Recruitment Business | MT |
| Mar. 20 | Opyl Requests Trading Halt After Receiving Offer For Opin Business | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Opyl Limited is an Australia-based company that provides biopharma and health organizations access to artificial intelligence (AI)-assisted technologies and professional guidance to understand and improve healthcare design, development and delivery. It has two core business streams: services and technologies. Its technology research and development pipeline provide life science developers and healthcare providers with unprecedented insight and data optimization opportunities. It has three key platforms in development that utilize artificial intelligence to analyze structured and unstructured data to deliver high value insights. Its platforms include clinical trial prediction and protocol design tool, clinical trial recruitment tool (Opin) and deep social media insights in healthcare. Its core services accessible at it include clinical trial recruitment, social media insights, market research and analysis and training and workshops. Its Opin is a clinical trial recruitment platform.
Calendar
2024-08-26
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -32.14% | 2.17M | |
| +4.26% | 32.15B | |
| +6.53% | 6.72B | |
| +15.28% | 3.68B | |
| -8.60% | 3.38B | |
| -28.12% | 1.21B | |
| -38.71% | 1.04B | |
| +0.50% | 893M | |
| -41.53% | 817M | |
| -26.60% | 813M |
- Stock Market
- Equities
- OPL Stock
- News Opyl Limited
- Opyl : Patient Recruitment Platform Signs MOU With Australian Regenerative Medicine Center
